{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:08:58Z","timestamp":1764835738762,"version":"3.46.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background\/aim:<\/jats:title>\n                    <jats:p>Statin medications (hydroxymethylglutaryl-CoA reductase inhibitors) are the agents most commonly used to lower lipids in people with dyslipidemia but are well known to exert unfavorable side effects such as myalgia, which may result in medication discontinuation. In this study, we aimed to assess the relationship between statin use and the development of gastric acid reflux symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An analytical cross-sectional study was conducted between October 2022 and December 2023 at King Saud University Medical City in Riyadh, Saudi Arabia, among individuals diagnosed with dyslipidemia who had used statin medications regularly for a minimum of 3\u00a0months. A simple random sampling technique was utilized. Patients were asked for demographic information, statin type, dose, duration, past medical history, and gastroesophageal reflux symptoms using the Ar-GerdQ tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 386 participants enrolled in our study. Participants\u2019 mean age and standard deviation was 55.4\u00a0\u00b1\u00a013.4\u00a0years, and the most used statin medication was atorvastatin (69.9%). The total mean GerdQ score was 6.40 (standard deviation 1.90), whereas only 11.4% of participants had gastric reflux symptoms. Different statin types, intensity, and duration were not statistically significantly correlated with gastric reflux symptoms (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). In comparison with those not using proton pump inhibitors, those who were using proton pump inhibitors were more frequently predicted to have an increased risk of developing gastroesophageal reflux disease (adjusted odds ratio\u00a0=\u00a02.991; 95% confidence interval: 1.359\u20136.585;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Statin medications were not associated with gastroesophageal symptoms, regardless of the statin type, dose, or intensity. Multicenter studies on a national level are warranted to affirm this conclusion further.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000003244","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:00:09Z","timestamp":1744182009000},"page":"3136-3142","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The prevalence of gastric reflux symptoms in Saudi Arabian statin-users, and associated factors: a tertiary-center cross-sectional observational study"],"prefix":"10.1097","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5290-1482","authenticated-orcid":false,"given":"Nasser M.","family":"AbuDujain","sequence":"first","affiliation":[{"name":"Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyad","family":"Aljofan","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Alhumimidi","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Batais","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazeed","family":"Almutairi","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saud","family":"Alsayed","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid F.","family":"Alsadhan","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah A.","family":"Alrasheed","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turky H.","family":"Almigbal","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"R1-20251204","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R2-20251204","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"R3-20251204","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-199732050-00005","article-title":"Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors: similarities and differences","volume":"32","author":"Lennern\u00e4s","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"R4-20251204","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.7164\/antibiotics.29.1346","article-title":"ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum","volume":"29","author":"Endo","year":"1976","journal-title":"J Antibiot (Tokyo)"},{"key":"R6-20251204","doi-asserted-by":"crossref","first-page":"J10","DOI":"10.1016\/0002-9149(88)90002-1","article-title":"Discovery, biochemistry and biology of lovastatin","volume":"62","author":"Alberts","year":"1988","journal-title":"Am J Cardiol"},{"key":"R8-20251204","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJM199006073222304","article-title":"Changes in risk factors and the decline in mortality from cardiovascular disease: the Framingham Heart Study","volume":"322","author":"Sytkowski","year":"1990","journal-title":"N Engl J Med"},{"key":"R9-20251204","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: mechanism of action and effects","volume":"5","author":"Stancu","year":"2001","journal-title":"J Cell Mol Med"},{"key":"R10-20251204","first-page":"199","article-title":"The pleiotropic effects and erapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in gastrointestinal tract disorders: a comprehensive review","volume":"22","author":"Cortes-Bergoderi","year":"2013","journal-title":"J Gastrointestin Liver Dis"},{"key":"R11-20251204","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/clc.22975","article-title":"Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): a survey on the patient perspective of dialogue with healthcare providers regarding statin therapy","volume":"41","author":"Brinton","year":"2018","journal-title":"Clin Cardiol"},{"key":"R12-20251204","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4103\/2230-8210.122602","article-title":"Management of statin intolerance","volume":"17","author":"Raju","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"R13-20251204","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jacl.2015.03.080","article-title":"Statin associated muscle symptoms: characteristics of patients and recommendations by providers","volume":"9","author":"Khan","year":"2015","journal-title":"J Clin Lipidol"},{"key":"R14-20251204","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pop.2017.07.001","article-title":"Gastroesophageal reflux disease","volume":"44","author":"Kellerman","year":"2017","journal-title":"Prim Care"},{"key":"R15-20251204","first-page":"641","article-title":"Statin use and risk of gastroduodenal ulcer and reflux esophagitis","volume":"56","author":"Fujii","year":"2009","journal-title":"Hepato-gastroenterology"},{"key":"R16-20251204","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2147\/TCRM.S114709","article-title":"Association of medications for lifestyle-related diseases with reflux esophagitis","volume":"12","author":"Asaoka","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"R17-20251204","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40261-017-0589-x","article-title":"Do statins increase the risk of esophageal conditions? Findings from four propensity score-matched analyses","volume":"38","author":"Smith","year":"2018","journal-title":"Clin Drug Investig"},{"key":"R18-20251204","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/s12889-023-15272-z","article-title":"Burden of gastroesophageal reflux disease in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of disease study 2019","volume":"23","author":"Li","year":"2023","journal-title":"BMC Public Health"},{"key":"R19-20251204","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1080\/07853890.2022.2074535","article-title":"Global, regional and national burden of gastroesophageal reflux disease, 1990\u20132019: update from the GBD 2019 study","volume":"54","author":"Zhang","year":"2022","journal-title":"Ann Med"},{"key":"R20-20251204","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/jpgm.JPGM_271_18","article-title":"Statins and gastroesophageal reflux disease: a meta-analysis","volume":"65","author":"Wijarnpreecha","year":"2019","journal-title":"J Postgrad Med"},{"key":"R21-20251204","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2021.05.016","article-title":"Trends in lipid-modifying agent use in 83 countries","volume":"328","author":"Blais","year":"2021","journal-title":"Atherosclerosis"},{"key":"R22-20251204","doi-asserted-by":"crossref","first-page":"100662","DOI":"10.1016\/j.oor.2024.100662","article-title":"How to choose a sampling technique and determine sample size for research: a simplified guide for researchers","volume":"12","author":"Ahmed","year":"2024","journal-title":"Oral Oncol Rep"},{"key":"R23-20251204","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/apt.12204","article-title":"Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease","volume":"37","author":"Jonasson","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R24-20251204","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/sjg.sjg_61_24","article-title":"Translation, cultural adaptation, and evaluation of the psychometric properties of the Arabic Gastroesophageal Reflux Disease Questionnaire (Ar-GerdQ)","volume":"30","author":"AbuDujain","year":"2024","journal-title":"Saudi J Gastroenterol"},{"key":"R25-20251204","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.2147\/PPA.S231873","article-title":"Adherence to statin therapy and attainment of LDL cholesterol goal among patients with type 2 diabetes and dyslipidemia","volume":"13","author":"Alwhaibi","year":"2019","journal-title":"Patient Prefer Adherence"},{"key":"R26-20251204","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/antiox11050856","article-title":"Nitrotyrosine, nitrated lipoproteins, and cardiovascular dysfunction in patients with type 2 diabetes: what do we know and what remains to be explained?","volume":"11","author":"Jakubiak","year":"2022","journal-title":"Antioxidants"},{"key":"R27-20251204","article-title":"Characteristics of high-resolution manometry and 24-hour pH monitoring in gastroesophageal reflux disease with ineffective esophageal motility","volume":"18","author":"Lee","year":"2024","journal-title":"Gut Liver"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:04:55Z","timestamp":1764835495000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003244","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"2024-12-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}